About Intersect Diagnostics
Intersect Diagnostics is a company based in Whitehall Township (United States) founded in 2019 by Boaz Kurtis. Intersect Diagnostics operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
- Headquarter Whitehall Township, United States
- Founders Boaz Kurtis
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intersect Diagnostics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$75 K (USD), Debt – Conventional
Mar 13, 2019
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Intersect Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Intersect Diagnostics
Investments & Acquisitions by Intersect Diagnostics
Investment portfolio details for Intersect Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intersect Diagnostics
Detailed financials for Intersect Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intersect Diagnostics Comparisons
Peer comparison for Intersect Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intersect Diagnostics
Intersect Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| Locked | Locked | Locked |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| Locked | Locked | Locked |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
Detailed competitors of Intersect Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intersect Diagnostics
Complete news archive for Intersect Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intersect Diagnostics
Intersect Diagnostics was founded in 2019.
Intersect Diagnostics is headquartered in Whitehall Township, United States. It is registered at Whitehall Township, Pennsylvania, United States.
Boaz Kurtis is the current CEO of Intersect Diagnostics. They have also founded this company.
Intersect Diagnostics was founded in 2019 in Whitehall Township, United States, within the biotechnology sector. Biomarkers are developed to support precision therapeutics. Image and processing test results are delivered to partners, with images digitized for tumor receptor expression detection. Secure data transfer specifications are utilized to ensure compliance and data integrity in operations.
Intersect Diagnostics's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.